Clinical Trials Directory

Trials / Completed

CompletedNCT02371993

Asthma in the Elderly: A Study of Choline Supplementation

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Rohr and Columbo Asthma, Allergy and Immunology Specialists, P.C. · Academic / Other
Sex
All
Age
65 Years
Healthy volunteers
Not accepted

Summary

Asthma in the elderly is poorly understood, as most studies have not included this patient group. In a previous study of adults with asthma, choline supplementation had a positive effect on asthma symptoms and allowed to decrease asthma pharmacologic treatment. The present study is a randomized, double-blind, placebo-controlled, cross-over study of choline supplementation. The investigators will study the effect of choline 650 mg taken orally twice daily x 6 weeks versus placebo on asthma symptom scores (Asthma Control Test) and spirometric values (FEV1, FEV1/FVC, FEF25-75%). The investigators will also look at the effect of choline supplementation on peripheral blood eosinophils, serum immunoglobulin E (IgE) and homocysteine levels.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTCholine
OTHERPlacebo

Timeline

Start date
2015-01-01
Primary completion
2015-06-01
Completion
2015-06-01
First posted
2015-02-26
Last updated
2015-10-29

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02371993. Inclusion in this directory is not an endorsement.